Tuesday 28 January 2020 ,
Tuesday 28 January 2020 ,
Latest News
  • Wage social movement against drugs, President to students
  • West Bengal Assembly passes resolution against CAA
  • Dhaka City Polls: BNP’s Tabith unveils election manifesto
  • Community-based prevention measures important to curbing pneumonia spread: China health authorities
  • 2 of a family die after ‘mysterious fever’ in Munshiganj
  • Afghan passenger plane crashes in Taliban-held eastern area
  • China virus toll leaps to 80 despite massive lockdown
26 August, 2019 00:00 00 AM

New drug for people who can bleed uncontrollably

BBC News Health
New drug for people who can bleed uncontrollably

Christopher Holmes has haemophilia A - his body lacks a protein that makes blood clot. A simple graze can mean the two-year-old bleeds uncontrollably.

To avoid this he needs treatment every few days with a drug put into his bloodstream via a tube in his chest.

But now, NHS England has agreed to fund a new therapy for patients like him.

It's a medication that can be given weekly or fortnightly as an injection just under the skin rather than into a vein.

Emicizumab, marketed as Hemlibra, mimics the action of the missing protein, factor VIII.

'Mummy, don't hurt me'

Christopher's doctors are recommending he stay on his current factor-VIII treatment but consider switching to the new one when he is a bit older. Like other people with haemophilia A, he will need life-long treatment.

His mother, Christy, 22, of Surrey, says: "Without treatment, there's the possibility that he could have multiple bleeds every week, every day.

"He is quite an active boy, so he bumps his head quite often and obviously there's always the chance of brain bleeds, and bleeds anywhere really, without that factor VIII.

"Christopher has severe haemophilia A. He has literally got no factor VIII in his body until we provide it to him."

Christopher copes really well with having his treatment - but it can be difficult.

"He's really good with it," Christy says.

"He's not scared of things or worried. To him, he's a normal child. We try as much as possible to treat him like a normal child. But a couple of weeks ago, he was in hospital because he had a port infection[, where the tube enters his chest].

"And sometimes he'll say to me, 'Mummy, don't hurt me,' when I'm doing his injection and that just kills you as a parent."

'Trailblazing drugs'

Haemophilia A is a genetic condition most often inherited but can occur spontaneously and usually affects boys and men.

Now, about 1,800 patients in England living with severe haemophilia A will potentially be able to have emicizumab.

People with less severe forms of the condition (but who have stopped responding to conventional factor-VIII treatment) have been able to get Hemlibra on the NHS in England, Scotland and Wales since 2018.

NHS chief executive Simon Stevens said: "Giving patients access to world-class, trailblazing drugs and therapies is a key part of the NHS Long Term Plan, which aims to save thousands more lives.

"As a parent, I know that cuts and scrapes happen to kids all the time but for many families these routine accidents can be distressing and life-threatening, so this new treatment will change lives and lift a weight from thousands of parents."

The Haemophilia Society chief executive Liz Carroll said: "This decision is fantastic news for our community.

"Current treatments can require intravenous infusions multiple times a week which can place a significant burden on people with haemophilia and their carers.

"This decision will mean that people will have the opportunity to have treatment less frequently without intravenous access, which will enable many to live their lives more freely.''

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

Leprosy or Hensen’s Disease is an infectious, chronic granulomatus disease caused by an acid and alcohol fast bacillus called Micobacterium Leprae.…
Q&A on Leprosy

Q&A on Leprosy

What is leprosy? Leprosy is a chronic, progressive bacterial infection caused by the bacterium Mycobacterium leprae. It primarily affects the nerves of…
Leprosy elimination

Leprosy elimination

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus. The disease mainly affects the skin, the peripheral…
Global Leprosy Strategy 2016-2020

Global Leprosy Strategy 2016-2020

The past three decades have witnessed some impressive advances in leprosy control. Elimination as a public health problem (i.e. registered prevalence…
Sepsis: Everything you need to know

Sepsis: Everything you need to know

Sepsis is a life-threatening illness caused by body's response to an infection. This infection injures its own tissues and organs, potentially leading…
Mystery virus in Wuhan identified as novel coronavirus

Mystery virus in Wuhan identified as novel coronavirus

Chinese authorities have been commended for the speed at which they have identified the genetic make up of a novel coronavirus, 2019-nCoV as the cause…
Belly fat linked with repeat heart attacks

Belly fat linked with repeat heart attacks

Heart attack survivors who carry excess fat around their waist are at increased risk of another heart attack, according to research published today in…
5 Things to do after your child is diagnosed with autism

5 Things to do after your child is diagnosed with autism

KACIE After my daughter was diagnosed with autism, I learned five important lessons I want to pass on to other families. There is a lot more to this list…
BAUS Conf 2020

BAUS Conf 2020

14th  BAUS Conference 2020 of Bangladesh Association of Bangladesh Association of Urological Surgeons was held at Intercontinental Hotel, Dhaka on…
'Alarming' one in five deaths due to sepsis

'Alarming' one in five deaths due to sepsis

JAMES GALLAGHER   One in five deaths around the world is caused by sepsis, also known as blood poisoning, shows the most comprehensive analysis of…
FDA warns of surgical gowns that may not be sterile

FDA warns of surgical gowns that may not be sterile

Certain surgical gowns and surgical packs made by Cardinal Health may not be sterile and should not be used, the U.S. Food and Drug Administration said…
FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

FDA approves Ozempic (semaglutide) for cardiovascular risk reduction in adults with Type 2 Diabetes and known heart disease

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Ozempic (semaglutide) injection 0.5 mg…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting